ロード中...
Endothelin antagonists in subarachnoid hemorrhage: what next?
In the previous issue of Critical Care, Ma and colleagues perform a meta-analysis of five randomized, clinical trials of endothelin antagonists in patients with aneurysmal subarachnoid hemorrhage. There are four trials using clazosentan and one trial with TAK-044. These studies show that endothelin...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3672573/ https://ncbi.nlm.nih.gov/pubmed/23146320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc11822 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|